Aspen Aerogels (NYSE:ASPN) Upgraded at B. Riley

Aspen Aerogels (NYSE:ASPN) was upgraded by stock analysts at B. Riley to a “strong-buy” rating in a research note issued to investors on Tuesday, Zacks.com reports.

ASPN has been the topic of several other reports. Piper Sandler upped their target price on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, May 29th. Canaccord Genuity Group upped their price target on shares of Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Craig Hallum upped their price target on shares of Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a report on Friday, June 14th. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a report on Wednesday, March 6th. Finally, TD Cowen upped their price target on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company a “buy” rating in a report on Wednesday, June 5th. One research analyst has rated the stock with a sell rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $30.75.

Aspen Aerogels Stock Down 1.2 %

Shares of NYSE:ASPN opened at $24.56 on Tuesday. Aspen Aerogels has a 1 year low of $5.32 and a 1 year high of $31.74. The business has a 50 day simple moving average of $25.35 and a two-hundred day simple moving average of $18.63. The firm has a market capitalization of $1.87 billion, a PE ratio of -55.82 and a beta of 2.29. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.14. The company had revenue of $94.50 million during the quarter, compared to analyst estimates of $73.04 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. On average, equities analysts predict that Aspen Aerogels will post 0.16 EPS for the current year.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 256,944 shares of the stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $29.24, for a total transaction of $7,513,042.56. Following the sale, the chief executive officer now directly owns 502,855 shares of the company’s stock, valued at approximately $14,703,480.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CEO Donald R. Young sold 256,944 shares of the stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $29.24, for a total transaction of $7,513,042.56. Following the sale, the chief executive officer now directly owns 502,855 shares of the company’s stock, valued at approximately $14,703,480.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Corby C. Whitaker sold 55,159 shares of the stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares in the company, valued at $3,289,640.33. The disclosure for this sale can be found here. Insiders have sold a total of 3,832,103 shares of company stock valued at $91,679,369 in the last ninety days. 4.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ASPN. Worth Venture Partners LLC purchased a new position in Aspen Aerogels in the 3rd quarter valued at about $3,684,000. Vanguard Group Inc. increased its holdings in shares of Aspen Aerogels by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company’s stock worth $29,635,000 after buying an additional 14,013 shares during the last quarter. Bouvel Investment Partners LLC increased its holdings in shares of Aspen Aerogels by 4.3% during the 4th quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company’s stock worth $1,488,000 after buying an additional 3,929 shares during the last quarter. Raymond James & Associates acquired a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $827,000. Finally, Raymond James Financial Services Advisors Inc. acquired a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $265,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.